TY  - JOUR
AU  - Piñana, Jose Luis
AU  - Lopez-Corral, Lucia
AU  - Martino, Rodrigo
AU  - Vazquez, Lourdes
AU  - Perez, Ariadna
AU  - Martin-Martin, Gabriel
AU  - Gago, Beatriz
AU  - Sanz-Linares, Gabriela
AU  - Sanchez-Salinas, Andres
AU  - Villalon, Lucia
AU  - Conesa-Garcia, Venancio
AU  - Olave, Maria T
AU  - Corona, Magdalena
AU  - Marcos-Corrales, Sara
AU  - Tormo, Mar
AU  - Hernandez-Rivas, Jose Angel
AU  - Montoro, Juan
AU  - Rodriguez-Fernandez, Alicia
AU  - Risco-Galvez, Irene
AU  - Rodriguez-Belenguer, Pablo
AU  - Hernandez-Boluda, Juan Carlos
AU  - Garcia-Cadenas, Irene
AU  - Ruiz-Garcia, Montserrat
AU  - Muñoz-Bellido, Juan Luis
AU  - Solano, Carlos
AU  - Cedillo, Angel
AU  - Sureda, Anna
AU  - Navarro, David
PY  - 2022
DO  - 10.1186/s13045-022-01275-7
UR  - http://hdl.handle.net/10668/20347
T2  - Journal of hematology & oncology
AB  - The clinical efficacy of SARS-CoV-2 vaccines according to antibody response in immunosuppressed patients such as hematological patients has not yet been established. A prospective multicenter registry-based cohort study conducted from December 2020 to...
LA  - en
PB  - BioMed Central
KW  - Allogeneic stem cell transplantation
KW  - Autologous stem cell transplantation
KW  - Breakthrough SARS-CoV-2 infection
KW  - COVID-19
KW  - Correlates of protection
KW  - Hematological malignancies
KW  - Immunocompromised patients
KW  - Moderna mRNA-1273
KW  - Pfizer-BioNTech BNT162b2
KW  - SARS-CoV-2 vaccines
KW  - Vaccine
KW  - Antibodies, Viral
KW  - BNT162 Vaccine
KW  - COVID-19 Vaccines
KW  - Cohort Studies
KW  - Hematologic Diseases
KW  - Humans
KW  - Prospective Studies
KW  - SARS-CoV-2
TI  - SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders.
TY  - research article
VL  - 15
ER  -